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Gated solely by activity-induced changes in intracel-
lular calcium, small-conductance potassium chan-
nels (SKs) are critical for a variety of functions in the
CNS, from learning and memory to rhythmic activity
and sleep. While there is a wealth of information on
SK2 gating, kinetics, and Ca2+ sensitivity, little is
known regarding the regulation of SK2 subcellular
localization. We report here that synaptic SK2 levels
are regulated by the E3 ubiquitin ligase UBE3A,
whose deficiency results in Angelman syndrome
and overexpression in increased risk of autistic spec-
trum disorder. UBE3A directly ubiquitinates SK2 in
theC-terminal domain, which facilitates endocytosis.
In UBE3A-deficient mice, increased postsynaptic
SK2 levels result in decreased NMDA receptor acti-
vation, thereby impairing hippocampal long-term
synaptic plasticity. Impairments in both synaptic
plasticity and fear conditioning memory in UBE3A-
deficient mice are significantly ameliorated by block-
ing SK2. These results elucidate a mechanism by
which UBE3A directly influences cognitive function.INTRODUCTION
Information processing in CNS circuits depends on synaptic ac-
tivity. In particular, synaptic transmission is modulated by
different small-conductance calcium-activated potassium chan-
nels (SKs), which either contribute to the afterhyperpolarization
that follows an action potential or facilitate repolarization
following excitatory postsynaptic potentials (EPSPs). SKs partic-
ipate in various CNS functions, from regulating neuronal intrinsic
excitability to network rhythmic activity and higher brain func-
tions (Adelman et al., 2012; Colgin et al., 2005; Ohtsuki et al.,
2012). In hippocampal CA1 pyramidal neurons, synaptic SK2s
are opened upon N-methyl-D-aspartate receptor (NMDAR) acti-
vation and repolarize the membrane, thereby terminating
NMDAR function (Ngo-Anh et al., 2005). This local feedback
loop between NMDARs and SK2s has been proposed to play a
critical role in regulating neuronal excitability and in controllingthe threshold for induction of long-term potentiation (LTP) (Ham-
mond et al., 2006; Lin et al., 2008). LTP induction also regulates
synaptic SK2 expression, as it triggers endocytosis of synaptic
SK2s (Lin et al., 2008).
Accumulating evidence indicates that a number of postsyn-
aptic proteins are ubiquitinated in an activity-dependent manner
(Colledge et al., 2003; Ehlers, 2003; Guo and Wang, 2007; Pat-
rick et al., 2003). Ubiquitination consists of modifying proteins
through E3-ligase-mediated ubiquitin attachment (Komander
et al., 2009). One of the E3 ligases, UBE3A, is critical for normal
brain function (Huibregtse et al., 1995), since its deficiency
causes Angelman syndrome (AS) (Williams et al., 1990) whereas
its overexpression is linked to an increased risk of autistic spec-
trum disorder (Cook et al., 1997). However, to date, very few
neuronal substrates of UBE3A have been identified. The current
study provides evidence that UBE3A directly ubiquitinates the
C-terminal domain of SK2, thereby facilitating its internalization.
Deficiency in this regulation accounts for impairments in LTP and
learning and memory found in UBE3A-deficient mice.RESULTS
Synaptic SK2 Levels Are Increased in Hippocampus of
UBE3A-Deficient Mice
Previous research from several groups, including our own, has
shown that LTP is impaired in maternal UBE3A-deficient (AS)
mice (Baudry et al., 2012; Jiang et al., 1998; van Woerden
et al., 2007). We hypothesized that UBE3A may directly regulate
synaptic SK2 expression and that its deficiency could contribute
to LTP impairment. Western blot analysis of proteins from
different hippocampal subcellular fractions (Figures S1A and
S1B) showed that SK2 levels were significantly higher in crude
synaptosomal (P2; Figure 1A) and PSD-enriched (P3; Figure 1B)
fractions of AS mice than in those fromwild-type (WT) mice. SK2
levels in whole hippocampal homogenates were not significantly
different betweenWT and ASmice (Figure S1C). Immunofluores-
cent staining showed that the highest levels of SK2 expression in
the hippocampal CA1 region were in cell bodies and dendrites of
pyramidal neurons (Figure 1C; Figure S1E). High-magnification
examination revealed that SK2-immunoreactive puncta were
distributed along apical dendrites and were partially co-localized
with PSD95- (Figure 1C) and synaptophysin-immunopositive
profiles (Figure S1E). Quantitative analysis showed that theCell Reports 12, 449–461, July 21, 2015 ª2015 The Authors 449
Figure 1. SK2 Expression in Hippocampus
of AS and WT Mice
(A and B) Western blot analysis of SK2 levels in (A)
crude synaptosomal fractions (P2) and (B) PSD
fractions (P3). Optical densities of the SK2 band
are normalized to those of b-actin or PSD-95.
Data are expressed as % of values in WT mice
and shown as means ± SEM of nine or ten (A)
or three mice (B) from at least three litters; ***p <
0.001 (unpaired t test) and **p < 0.01 (unpaired
t test).
(C) Localization of synaptic SK2 in AS mice.
Representative images of CA1 pyramidal neurons
stained with anti-SK2 (red) and -PSD95 (green)
antibodies. Arrowheads indicate clearly co-local-
ized puncta. Scale bar represents 20 mm (left) or
10 mm (right).
(D) Quantitative analysis of the number of SK2-
immunoreactive puncta and percentage of SK2
and PSD95 dually stained puncta/synapses in
hippocampal CA1 region. Shown are means ±
SEM; n = 18–24 regions of interest from at least
nine slices from at least three mice per group
(unpaired t test, ***p < 0.001).
See also Figure S1.number of SK2-immunopositive puncta wasmarkedly increased
in AS mice (Figure 1D). The percentage of puncta dually stained
with SK2 and PSD95 (Figure 1D) or SK2 and synaptophysin (Fig-
ure S1F) was also significantly increased in AS mice. There was
no significant difference in the overall number of PSD95-immu-
nopositive puncta between AS and WT mice (Figure S1D).
Reduced SK2 Protein Ubiquitination in Hippocampus of
AS Mice
Next, we determined whether the increase in synaptic SK2 levels
in AS mice was due to the lack of UBE3A-mediated ubiquitina-
tion. Immunofluorescent staining showed that UBE3A and SK2
were co-localized in puncta along apical dendrites of CA1 pyra-
midal neurons (Figure 2A) and dendrites of cultured hippocampal
neurons fromWTmice (Figure S2A). Immunoprecipitation exper-
iments showed that SK2 co-immunoprecipitated with UBE3A
(Figure 2B, top) and UBE3A co-immunoprecipitated with SK2
(Figure 2B, bottom). Furthermore, the amount of ubiquitinated
proteins in SK2 antibody pull-down samples from AS mice
was decreased compared to that in WT mice (arrows in Fig-
ure 2C). Immunoprecipitation of SK2 by SK2 antibody and ubiq-
uitination of UBE3A were also determined (Figures S2B and
S2C). Immunoprecipitation performed under denaturing condi-
tions confirmed that SK2 was ubiquitinated and that its ubiquiti-
nation was reduced in AS mice compared to WT mice (arrows in
Figure 2D).
UBE3A Ubiquitinates SK2
To determine whether UBE3A could ubiquitinate SK2 in vitro, we
first incubated a purified GST-SK2 C-terminal domain (SK2-C)
with ubiquitin, E1, E2, and ATP in the presence or absence of re-
combinant UBE3A. Under these conditions, UBE3A markedly450 Cell Reports 12, 449–461, July 21, 2015 ª2015 The Authorsincreased SK2-C ubiquitination (Figure 3A). The presence of
UBE3A and SK2-C was verified by western blots (Figures 3A
and S3A).
UBE3A-mediated SK2-C ubiquitination was then confirmed
using COS-1 cells transfected with a chimeric construct (Tac-
SK2) containing the N-terminal and transmembrane domains
of Tac, a constitutively expressedmembrane protein (Bonifacino
et al., 1990), and the SK2 C terminus. Tac chimeric constructs
have been widely used to study membrane protein trafficking
(Mu et al., 2003; Standley et al., 2000). Given that COS-1 cells ex-
press endogenous UBE3A, we determined the effect of small
interfering RNA (siRNA)-mediated knockdown of UBE3A on
SK2-C ubiquitination using a His-ubiquitin pull-down assay.
COS-1 cells were first incubated with either UBE3A siRNA or a
scrambled control siRNA, followed by transfection with Tac-
SK2-C and His-ubiquitin. SK2-C ubiquitination was moderately
reduced (30% ± 1% reduction in UBE3A siRNA treated
compared to control siRNA treated; p < 0.001, n = 3) following
UBE3A siRNA treatment (Figure 3B, bottom), to an extentmatch-
ing that of UBE3A reduction (Figure 3B, top; 33% ± 4%; p < 0.01,
n = 3). In contrast, overall protein ubiquitination was not affected
(Figure S3B). We repeated the experiments with full-length SK2
(SK2-FL) and obtained similar results (Figure S3C). Thus, results
from direct ubiquitination assay and His-ubiquitin pull-down
analysis showed that SK2 is ubiquitinated in its C terminus by
UBE3A.
Lysine Residues K506, K514, and K550 in the SK2
C-Terminal Domain Are Critical for UBE3A-Mediated
Ubiquitination
Multiple lysine residues are present in SK2 C terminus, with
several in the calmodulin-binding domain (CaMBD; Figure S3D).
Figure 2. Interactions between UBE3A and SK2 and SK2 Ubiquitination in Hippocampal Membrane Fractions from WT and AS Mice
(A) Localization of UBE3A (green) and SK2 (red) in dendritic spines along apical dendrites of CA1 pyramidal neurons from aWTmouse (arrowheads indicate clear
co-localization). Scale bar represents 20 mm (left) or 5 mm (right).
(B) Interactions between UBE3A and SK2 in hippocampal P2 fractions. Top: western blot analysis with anti-UBE3A and -SK2 antibodies of immunoprecipitation
performed with anti-UBE3A antibodies (+) or control immunoglobulin G (IgG) (). SK2 is clearly co-immunoprecipitated with UBE3A in WT mice. Bottom:
immunoprecipitation was performed with anti-SK2 antibodies, and western blots were labeled with anti-UBE3A antibodies. UBE3A is co-immunoprecipitated
with SK2 in WT mice and in AS mice, albeit with reduced amount. Asterisk indicates non-specific bands in control IgG groups. Mol-M, molecular weight marker.
(C) Immunoprecipitation was performed with anti-SK2 antibodies, and western blots were labeled with anti-SK2 and -ubiquitin (Ub) antibodies. Arrows indicate
ubiquitinated SK2 and/or SK2-associated proteins. Right: quantification of the relative abundance of ubiquitinated SK2 and/or SK2-associated proteins in
hippocampus of WT and AS mice (mean ± SEM, *p < 0.05 compared to WT mice, n = 3, Student’s t test).
(D) Immunoprecipitation under denaturing conditions was performed with anti-SK2 antibodies or control IgG and western blots were labeled with anti-ubiquitin
antibodies. Arrows indicate ubiquitinated SK2. Right: quantification of the relative abundance of ubiquitinated SK2 in hippocampus of WT and AS mice (mean ±
SEM, ***p < 0.001 compared to WT mice, n = 3, Student’s t test).
See also Figure S2.Given that calmodulin is constitutively bound to CaMBD, we tar-
geted the three lysine residues after the CaMBD (Figure 3C). Of
note, in silico molecular docking showed that K506 and K514,
which are present in the crystal structure of the SK2 C-terminal
helix, face the binding grove of UBE3A, where C604, C737,
and the catalytic C820 are located (Figure 3D). We simulta-
neously mutated residues K506, K514, and K550 to alanine
(DK) in Tac-SK2-C and co-transfected this construct in COS-1
cells with either wild-type UBE3A (UBE3A) or its inactive form
UBE3A-C833A (Kumar et al., 1999) (referred to asDUBE3A here-
after) to determine whether these mutations affected SK2-C
ubiquitination and whether ubiquitination was also influenced
by the amount of functional UBE3A. Tac-SK2-C co-immunopre-
cipitated with UBE3A and much less with DUBE3A (Figure S3E),
suggesting that interaction between functional UBE3A and SK2
C terminus is involved in SK2 ubiquitination. The His-ubiquitin
pull-down assay showed that co-transfection with UBE3A, butnot DUBE3A, resulted in massive SK2-C ubiquitination, which
was significantly reduced by K-A mutation (84% ± 5% reduction
compared to UBE3A/Tac-SK2-C group; p < 0.001, n = 3) (Fig-
ure 3E, bottom). Again, overall protein ubiquitination was not
affected (Figure S3F). These results confirmed that SK2s are
ubiquitinated by UBE3A at K506/K514/K550 in the C-terminal
domain.
To test whether these lysine residues are also involved in
UBE3A-mediated ubiquitination in vivo, we synthesized two
short peptides around K550 (PM101 and PM102; see Experi-
mental Procedures). We first tested whether these peptides
could disrupt the interaction between SK2 andUBE3A in P2 frac-
tions of hippocampus from WT mice. Immunoprecipitation ex-
periments showed that the amount of SK2 in UBE3A antibody
pull-down products was decreased by incubation with peptides
PM101 and PM102 at 50 mM (Figure 3F). Immunoprecipitation of
UBE3A by UBE3A antibody was also determined (Figure 3F). ToCell Reports 12, 449–461, July 21, 2015 ª2015 The Authors 451
Figure 3. UBE3A Ubiquitinates SK2 in the
C-Terminal Domain
(A) In vitro ubiquitination of SK2 by recombinant
UBE3A. Reaction products were analyzed by
western blot with UBE3A (top), SK2 (middle), or
ubiquitin (Ub, bottom) antibodies. Note that ubiq-
uitin and SK2 dually labeled high molecular bands
(SK2-(Ub)n) are present only when all reaction
elements and ATP were added.
(B) siRNA knockdown of UBE3A in COS-1 cells
reduces SK2 ubiquitination. COS-1 cells were
incubated with UBE3A siRNA or scrambled control
siRNA 24 hr before transfection with Tac-SK2 and
His-ubiquitin. Twenty-four h later, ubiquitinated
proteins were isolated by Co2+-affinity chroma-
tography. Levels of ubiquitinated Tac-SK2 protein
(SK2-(Ub)n, bottom) were determined by western
blot. Levels of input proteins were also evaluated
by western blot probed with UBE3A, SK2, and
b-actin antibodies (top).
(C) Candidate UBE3A ubiquitination sites (K506/
K514/K550) within SK2 C terminus. CaMBD,
calmodulin-binding domain.
(D) Docking of SK2 C-terminal helix (PDB: 2PNV,
chain A 488–526) into UBE3A (PDB: 1D5F). K506
and K514 in the SK2 C-terminal helix are shown in
stick representation. C604 and C737 in the larger
N-terminal lobe of UBE3A are shown as yellow
balls, and catalytic C820 in the smaller C-terminal
lobe is shown in red.
(E) K506A/K514A/K550A (DK) mutations in
SK2 block UBE3A-mediated SK2 ubiquitination.
UBE3A overexpression enhances and K506A/
K514A/K550A mutations block SK2 ubiquitination
in COS-1 cells. His-tagged ubiquitinated proteins
in cells co-transfected with either Tac-SK2 plus
UBE3A or DUBE3A or DK plus UBE3A were
precipitated using Talon resin and probed with
anti-SK2 antibody (bottom). Ubiquitinated SK2 are
labeled with ‘‘SK2-(Ub)n.’’ Top: input of UBE3A,
SK2, and b-actin.
(F) Binding of SK2 with UBE3A is interrupted
by PM101 and PM102 peptides. Hippocampal
P2 fractions from WT mice were incubated
in the presence or absence of PM101 or
PM102 (50 mM) peptides followed by immu-
noprecipitation with either anti-UBE3A anti-
bodies or control IgG. Western blots were per-
formed with anti-UBE3A or anti-SK2 antibodies.
Levels of SK2 co-immunoprecipitated with
UBE3A were decreased by peptides PM101
or PM102.
(G) Binding of SK2 with UBE3A and its ubiquiti-
nation in vivo were disrupted by systemic admin-
istration of the TAT-101 peptide. WT mice were
injected with either control TAT or TAT-101 (i.p.
50 mg/kg), and hippocampi were collected 2 hr
later for immunoprecipitation and western blot.
Immunoprecipitation under denaturing conditions
was performed with anti-SK2 antibodies or control IgG, and western blots were labeled with anti-ubiquitin antibodies (right). Arrows indicate ubiquitinated SK2
species. Levels of input proteins were also evaluated by western blot probed with SK2 and b-actin antibodies (left).
See also Figure S3.allow for efficient delivery of the peptide across the blood-brain
barrier, we conjugated PM101 to the cell membrane transduc-
tion domain of HIV-1 Tat protein (TAT-101). It is well established452 Cell Reports 12, 449–461, July 21, 2015 ª2015 The Authorsthat peptides/proteins that are fused to TAT are rapidly and effi-
ciently introduced into live tissues when systemically adminis-
tered into intact animals while retaining their biological activity
(Rapoport and Lorberboum-Galski, 2009; Xu et al., 2007). Four-
month-oldWTmice were injected with either control TAT or TAT-
101 (intraperitoneally [i.p.], 50 mg/kg) and hippocampi collected
2 hr later. Western blot results showed that SK2 levels in P2 frac-
tions were significantly increased following TAT-101 treatment
(11% ± 3%; p < 0.01, n = 4) compared to TAT control (Figure 3G).
Immunoprecipitation performed under denaturing conditions
confirmed that SK2 ubiquitination was also reduced in TAT-
101-treated mice (30% ± 3%, p < 0.001; n = 3) compared to
control TAT-treated mice (arrows in Figure 3G). These results
indicate that sequences around K550 in the SK2 C-terminal
domain are critical for both interaction with and ubiquitination
by UBE3A in vivo.
UBE3A-Mediated Regulation of SK2 Surface Expression
and Endocytosis Depends on K506/K514/K550
To further understand the role of UBE3A-mediated SK2 ubiquiti-
nation, we analyzed SK2 surface expression and endocytosis
first in COS-1 cells. Tac-SK2 surface expression, detected with
a Tac-specific antibody, was significantly reduced following
co-transfection with UBE3A but was markedly increased
following DUBE3A co-transfection (Figures 4A and 4B, left; Fig-
ure S4A). In contrast, co-transfection with either UBE3A or
DUBE3A did not affect surface expression of a similar construct
consisting of Tac and the C-terminal domain of the AMPA recep-
tor (AMPAR) subunit, GluA2 (Tac-GluA2; Figure S4B). Results
similar to those obtained with Tac-SK2 were obtained with full-
length SK2 (Figure S4C). The effects of UBE3A and/or DUBE3A
on Tac-SK2 surface expression were also confirmed by western
blots from cell membrane fractions, although co-transfection of
Tac-SK2 with UBE3A or DUBE3A did not significantly alter SK2
levels in whole homogenates (Figure S4D). K-A mutation at
K506/K514/K550 (DK) significantly increased surface expression
and eliminated the effect of UBE3A (Figure 4A, right; and Fig-
ure 4B, left). In endocytosis assays, UBE3A significantly
increased, while DUBE3A significantly reduced, Tac-SK2 inter-
nalization (Figures 4A, left, and 4B, right; Figure S4E). K-A muta-
tion significantly reduced SK2 endocytosis and eliminated the
effect of UBE3A (Figures 4A and 4B, right). Similar results were
obtained when lysine residues K506/K514/K550 were changed
to arginine (DK2; Figure S4E). These results suggest that
UBE3A facilitates SK2 endocytosis, possibly by ubiquitination
of K506/K514/K550 residues.
To determinewhether UBE3A-mediated regulation of SK2 sur-
face expression and endocytosis in COS-1 cells also occurred in
neurons, we cultured hippocampal neurons fromAS andWT em-
bryos. We first confirmed that SK2 levels were higher in mem-
brane fractions from cultured hippocampal neurons of AS mice
compared to WT mice (Figure 4C). We then performed bio-
tinylation assay to detect surface-expressed and internalized
SK2s in cultured hippocampal neurons. The results showed
that levels of membrane-associated SK2s were significantly
higher in AS neurons than in WT neurons (Figure 4D). While sig-
nificant amounts of SK2s were detected in the endocytotic frac-
tion fromWT neurons, SK2s were barely detectable in the similar
fraction from AS mice neurons (Figure 4D). In contrast, GluA1
was detectable in the endocytotic fraction from both WT and
AS mice (Figure 4D). These results reveal a specific UBE3A-dependent regulation of SK2 endocytosis in hippocampal
neurons.
Increased SK2s Result in Synaptic Plasticity Impairment
and Decreased NMDAR Function in AS Mice
To determine whether changes in SK2 synaptic expression
contributed to LTP impairment in AS mice, we determined the
effects of apamin, a selective SK2 blocker, on LTP in acute
hippocampal slices. As previously reported, theta-burst stimula-
tion (TBS) induced LTP in field CA1 of hippocampal slices in
WT mice, whereas it elicited only transient facilitation in AS
mice (Figures 5A and 5B, red trace). Following pre-incubation
of hippocampal slices from AS mice with apamin (20 nM),
TBS-elicited LTP was identical to that in WT mice (Figures 5A
and 5B, blue trace). Apamin at this concentration did not affect
TBS-induced LTP in slices from WT mice (Figures 5A and 5B,
pink trace), nor did it affect baseline synaptic responses or re-
sponses in a control pathway (Figures 5A, 5B, and S5A) or
paired-pulse facilitation (Figure S5B) in slices from either WT or
AS mice.
Like LTP, long-term depression (LTD) of synaptic transmission
is also generally assumed to be involved in learning andmemory.
We therefore determined whether LTD was altered in AS mice.
Low-frequency stimulation (LFS; 1 Hz, 15 min) of the Schaffer
collaterals in hippocampal slices from 3-month-old WT mice
induced a transient synaptic depression, and synaptic re-
sponses slowly returned to baseline levels (Figure 5C, white cir-
cle, top), a result consistent with the literature (Dudek and Bear,
1993). However, the same protocol induced sustained LTD in sli-
ces from 3-month-old ASmice (Figure 5C, red circle in top). Apa-
min (20 nM) pre-treatment significantly reduced LTD in AS mice
(Figures 5C and 5D, blue in the top) and did not affect responses
to low-frequency stimulation in slices from WT mice. Since
induction of both LTP and LTD at Schaffer collateral-CA1
synapses is NMDAR dependent and SK2-mediated hyperpolar-
ization inhibits NMDAR-channel opening, we analyzed the effect
of apamin treatment on NMDAR-mediated synaptic responses
(NfEPSPS). NfEPSPs were isolated by bath application of a
Mg2+-free ACSF containing 6-cyano-7-nitroquinoxaline-2,3-di-
one (CNQX; 10 mM) to block AMPA-receptor-mediated synaptic
transmission. The NMDAR antagonist AP5 was used to verify
that NfEPSPs were mediated by NMDARs under these condi-
tions (Figure 5E). NfEPSP amplitudes were significantly lower in
AS mice compared to WT mice, and this decrease was reversed
by apamin application (Figures 5F, 5G, and S5C), suggesting
that SK2 imposes a stronger inhibition of NMDAR in AS mice
than in WT mice. At this concentration, apamin did not signifi-
cantly increase NfEPSP in WT mice (Figures 5F and 5G). AP5
pre-treatment also significantly reduced LTD in AS mice (Fig-
ure S5D), suggesting that the enhanced LTD in AS mice is also
NMDAR dependent.
To confirm that increased SK2 activity was due to the lack of
UBE3A-mediated regulation, we determined the effect of the
TAT-101 peptide on LTP induction in WTmice. Hippocampal sli-
ces were prepared 2 hr after administration of either control TAT
or TAT-101 peptide (i.p., 50 mg/kg). In hippocampal slices from
TAT-101-treated mice, TBS induced only a transient enhance-
ment in synaptic responses, as found in slices from AS mice.Cell Reports 12, 449–461, July 21, 2015 ª2015 The Authors 453
Figure 4. UBE3A Regulates SK2 Surface Expression and Endocytosis in COS-1 Cells and Cultured Hippocampal Neurons
(A and B) Effects of UBE3A overexpression and K-A mutation on SK2 surface expression and endocytosis. (A) Representative images of internalized (red) or
surface-expressed (green) Tac-SK2 (lefts) and DK (right) in COS-1 cells co-transfected with HA (top), HA-UBE3A (middle), or HA-DUBE3A (bottom). Scale bar,
10 mm. (B) Quantitative analysis of images in (A). Data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 compared to Tac-SK2/HA (Tac-SK2);
two-way ANOVA with Newman-Keuls post hoc analysis. n is indicated in each column and from at least three independent experiments.
(C and D) Regulation of SK2 membrane expression and internalization by UBE3A in cultured hippocampal neurons. (C) Top: representative blots of UBE3A,
SK2, and b-actin in P2 fractions. Bottom: quantitative data (mean ± SEM; n = 10–11 E18 mouse embryos; unpaired Student’s t test, **p < 0.01). (D) Biotinylation
assays of SK2 and GluA1 (used as control) endocytosis with hippocampal neurons. Biotinylated SK2 and GluA1 were isolated by NeutrAvidin precipitation
and detected by western blot with SK2 and GluA1 antibodies (lower left). Upper left: levels of SK2 and GluA1 in whole homogenate (input). Upper right: ratio
(legend continued on next page)
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In contrast, LTP was intact in hippocampal slices from control
TAT-treated mice (Figures 5H and 5I).
We previously showed that LTP impairment in AS mice was
associated with reduced actin polymerization following TBS
application (Baudry et al., 2012). Therefore, we determined the
effect of apamin application on TBS-induced actin polymeriza-
tion using Alexa-Fluor-568-conjugated phalloidin, which selec-
tively binds to filamentous actin (F-actin). TBS elicited a clear
increase in the number of F-actin-positive puncta in WT slices,
but not in AS slices. Apamin pre-treatment markedly enhanced
TBS-induced actin polymerization in AS slices (Figure S6).
Increased SK2s Alter TBS-Induced LTP Properties in
AS Mice
Recent studies have revealed that TBS-induced LTP is followed
by a refractory period (1 hr) during which another TBS cannot
enhance LTP magnitude, while multiple TBS trains separated
by longer time intervals are able to increase LTPmagnitude (Kra-
ma´r et al., 2012). This LTP property was tested in hippocampal
slices from AS mice by applying a second TBS (TBS2) train at
10, 45, or 60 min after the first TBS (TBS1). As previously re-
ported (Lynch et al., 2013), TBS2 applied 10 min (Figure 6B)
post-TBS1 in WT hippocampal slices failed to further enhance
LTPmagnitude, while after 60 min (Figure 6A), TBS2 significantly
increased LTP magnitude. In contrast, TBS2 applied at 10 min
(Figure 6B) or 45 min (Figures S7A and S7B) after TBS1 in AS
hippocampal slices significantly enhanced LTP magnitude to a
level comparable to that found in WT mice. In addition, when
applied 60min (Figure 6A) after TBS1, TBS2 failed to significantly
increase LTP.
Quantitative image analysis showed that TBS1 stimulation
induced a significant reduction in the percentage of SK2-immu-
nopositive synapses inWTmice, a result in good agreement with
a previous study (Lin et al., 2008). In AS mice, TBS1, although
unable to induce LTP, produced a similar reduction in the per-
centage of SK2-immunopositive synapses, suggesting that
TBS1-elicited SK2 internalization enables TBS2 to induce LTP
shortly after TBS1 (Figures 6D and 6E). This idea was further sup-
ported by the fact that following pre-incubation with apamin in
AS slices, TBS2 applied 10 min after TBS1 did not further
enhance LTP (Figure 6C).
Treatment with Apamin Improves Learning and Memory
Performance of AS Mice in the Fear-Conditioning
Paradigm
To determine whether apamin could also reverse impairment in
hippocampus-dependent learning in AS mice, we used the
fear-conditioning paradigm. AS and WT mice were injected
with apamin (0.4 mg/kg, i.p.) 30 min before the training session,
as previously reported (Vick et al., 2010). AS mice were impaired
in a context-dependent fear conditioning and tone test, and apa-
min treatment significantly enhanced learning performance in AS
mice (Figure 7). Under our experimental conditions (three condi-(mean ± SEM of three independent experiments) of surface-expressed SK2 over
internalized SK2 over surface-expressed SK2. **p < 0.01, unpaired Student’s t te
proteins.
See also Figure S4.tioned stimuli [CS] paired with three unconditioned stimuli [US]),
apamin treatment did not affect learning in WT mice. Addition-
ally, there was no difference in freezing time in the pre-condition-
ing period, during training, or before tone application in the
testing period among all experimental groups (Figure S7C).
DISCUSSION
Our results indicate that UBE3A-mediated regulation of synaptic
SK2s plays critical roles in synaptic plasticity and learning and
memory. SK2 and UBE3A were co-localized in dendrites and
spines of hippocampal pyramidal neurons, and lack of UBE3A
resulted in increased synaptic SK2 levels and decreased SK2
ubiquitination. SK2 was ubiquitinated by UBE3A at residues
K506/K514/K550 in its C-terminal domain, resulting in SK2 inter-
nalization. Both the interaction between SK2 and UBE3A and
SK2 ubiquitination were significantly reduced by small peptides
that comprise the SK2 C-terminal sequence around residue
K550. Electrophysiological studies revealed that increased SK2
levels imposed a tonic inhibition of NMDARs, accounting for
impairments in TBS-induced LTP and actin polymerization in
hippocampal slices from AS mice. The interaction-disrupting
peptide TAT-101 produced LTP impairment in slices from WT
mice, similar to that observed in AS mice. In vivo experiments
demonstrated that increased synaptic SK2 levels also contrib-
uted to learning and memory deficits in the fear-conditioning
paradigm. Together, these results not only indicate that SK2 is
a substrate of UBE3A but also reveal a mechanism by which
UBE3A regulates synaptic plasticity and cognitive functions.
UBE3A Ubiquitinates SK2s in Their C-Terminal Domain,
Resulting in Their Endocytosis
Several synaptic proteins are regulated by the ubiquitin-protea-
some system (for recent reviews, see Lin and Man, 2013; Mabb
and Ehlers, 2010). For instance, PSD-95 is ubiquitinated by the
E3 ligase Mdm2 leading to subsequent degradation by protea-
somes in response to NMDAR activation (Colledge et al.,
2003). PSD-95 ubiquitination also results in increased AMPAR
internalization, possibly through a non-proteolytic function, i.e.,
by interacting with and enhancing clathrin-dependent endocy-
tosis (Bianchetta et al., 2011). Both NMDARs and AMPARs are
also modified by protein ubiquitination; the NMDAR subunit
GluN2B is ubiquitinated by the RING family E3 ligase Mib2
(Jurd et al., 2008), the AMPAR subunit GluA1 by Nedd4 (Lin
et al., 2011), and GluA2 by an undefined E3 ligase (Lussier
et al., 2011). Our results add to this list another member of post-
synaptic proteins by showing that UBE3A ubiquitinates SK2 in its
C-terminal domain, on lysine residues K506, K514, and K550.
Mutations of these lysine residues to either alanine or arginine
not only reduced SK2 channel endocytosis and increased their
surface expression but also eliminated UBE3A-mediated SK2
ubiquitination and endocytosis. Finally, the endocytosis-bio-
tinylation assay showed that, whereas SK2 was detectable intotal SK2. Lower right: ratio (mean ± SEM of three independent experiments) of
st. Str, samples from stripped dish; Sur, total surface proteins; En, internalized
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Figure 5. Impairment of NMDAR-Depen-
dent Hippocampal Synaptic Transmission
and Activity-Dependent Synaptic Plasticity
in Hippocampal Slices from AS Mice
(A) Reversal of LTP impairment in AS mice by
apamin, an SK2 channel blocker. Slopes of field
excitatory postsynaptic potential (fEPSPs) were
normalized to the average values recorded during
the 10-min baseline. Insert shows representative
traces of evoked fEPSPs before and 40 min after
TBS (arrow). Scale bar, 0.5 mV/10 ms.
(B) Mean ± SEM of fEPSPs (expressed as% of WT
control pathway) measured 40 min after TBS in
different groups. *p < 0.05 (one-way ANOVA fol-
lowed by Bonferroni test).
(C) LTD in hippocampal slices from AS mice is
blocked by apamin. Top: LTD induced by LFS
(1 Hz for 15 min). Bottom: effect of apamin on
control pathway.
(D) Mean ± SEM of fEPSPs measured 40 min after
LFS in different groups. *p < 0.05 (one-way ANOVA
followed by Bonferroni test).
(E) Protocol and time points used for analysis of
NMDAR-mediated synaptic transmission (NfEPSP).
(F and G) Representative traces (G) and quantifi-
cation of NfEPSPs (F) recorded at the time points
indicated in (E). Data are means ± SEM expressed
as % of values in WT hippocampal slices before
apamin treatment (WT control); *p < 0.05 compared
to WT control; #p < 0.05 compared to AS control
(two-way ANOVA followed by Bonferroni test).
Traces of AMPAR fEPSPs indicate that synaptic
responses before initiation of NfEPSP recording are
similar between AS and WT mice. Scale bar,
0.5 mV/20 ms.
(H) Systemic injection of peptide TAT-101 impaired
LTP induction in WT mice. Insert shows represen-
tative traces of evoked fEPSPs before and 30 min
after TBS (arrow). Scale bar, 0.5 mV/10 ms.
(I) Mean ± SEM of fEPSPs measured 30 min after
TBS in the two groups. ***p < 0.001 (Student’s
t test).
See also Figures S5 and S6.
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Figure 6. UBE3A-Deficiency-Induced Changes in LTP Properties
(A) Two TBS (arrows) separated by 60 min could induce further potentiation in hippocampal slices from WT mice, while neither the first or second TBS induced
LTP in hippocampal slices from AS mice.
(B) A second TBS(2) applied 10 min after the first TBS(1) did not induce further potentiation in slices fromWT mice. However, the same TBS2 was able to induce
LTP in hippocampal slices from AS mice.
(C) With apamin pre-application, TBS2 applied 10 min post TBS1 was not able to further enhance LTP in AS mice.
(D) TBS elicited a decrease in the number of SK2-positive synapses in both WT and AS mice. Shown are representative images of SK2 (red) and PSD95 (green)
immunostaining in the CA1 region of WT and AS mice (Scale bar, 10 mm).
(E) Quantitative results (mean ± SEM) of synapses dually labeled by anti-SK2 and anti-PSD95 antibodies in different experimental groups (*p < 0.05, n = 3 slices
from three mice/group, one-way ANOVA followed by Bonferroni test).
See also Figure S7.both cell membrane and endocytotic fractions in neurons
cultured from WT mice, it was only observed in cell membrane
fractions in neurons from AS mice, suggesting that UBE3A defi-
ciency impairs tonic SK2 endocytosis. The reduction in SK2
endocytosis could account for the increased SK2 levels in crude
synaptosomal and PSD fractions found in hippocampus of
AS mice.
Roles of UBE3A-Mediated SK2 Regulation in Synaptic
Plasticity
We previously reported that a semi-chronic treatment with an
AMPAR-positive regulator, CX929, reversed LTP impairment
in AS mice, possibly due to increased brain-derived neurotro-
phic factor (BDNF) production. In the current study, we showed
that acute apamin application in hippocampal slices was able
to restore TBS-induced LTP in AS mice. BDNF has been shownto facilitate NMDAR-mediated LTP, and, as we discussed,
apamin treatment also increases NMDAR activity. Thus,
CX929 and apamin treatments converge on NMDARs and
possibly on downstream signaling pathways as well, since
both CX929 treatment and apamin application were able to
restore actin polymerization in dendritic spines following LTP in-
duction. We therefore argue that LTP impairment in AS mice
takes place at the induction phase, possibly due to insufficient
NMDAR activation, and we postulate that any manipulation that
enhances LTP induction could be beneficial to re-establish
normal synaptic plasticity in AS mice. In addition, treatments
bypassing the induction stage and directly activating down-
stream signaling cascades, such as increasing CaMKII activity
(van Woerden et al., 2007) or promoting cytoskeletal remodel-
ing (Baudry and Bi, 2013; Lynch et al., 2008), could be benefi-
cial as well.Cell Reports 12, 449–461, July 21, 2015 ª2015 The Authors 457
Figure 7. Effects of Apamin Treatment on
Fear Conditioning in WT and AS Mice
(A) Percent freezing for different experimental
groups in context memory (mean ± SEM of 16–20
mice; ***p < 0.001 compared to WT controls;
#p < 0.05 compared to vehicle-treated AS mice;
two-way ANOVA with Newman-Keuls post hoc
analysis).
(B) Cumulative distribution of% freezing inWT and
AS mice treated with vehicle or apamin assessed
by the Kolmogorov-Smirnov test in context mem-
ory (***p < 0.001 compared to WT controls; #p <
0.05 compared to vehicle-treated AS mice).
(C and D) Cumulative distribution and % freezing
for different experimental groups in tone memory
(mean ± SEM of 9–11 mice; *p < 0.05 and **p <
0.01 compared to WT controls; #p < 0.05
compared to vehicle-treated AS mice).
See also Figure S7.Recently, a series of studies has revealed that LTP has a re-
fractory period lasting 1 hr after TBS (Lynch et al., 2013). We
recently found that two different isoforms of the calcium-acti-
vated protease, calpain, play a critical role in LTP induction
and the initiation of the refractory period (Wang et al., 2014).
These findings provide a biological basis for the widely recog-
nized phenomenon that new information is better retained with
spaced-trial learning than with massed-trial learning (Benjamin
and Tullis, 2010). In the present study, we found that at inter-
vals%45min, TBS2was able to induce LTP in ASmice, suggest-
ing that a short lasting process triggered by TBS1 was sufficient
for facilitating LTP induction in AS mice. Since TBS2 delivered at
10-min intervals did not further enhance LTP in apamin pre-
treated slices, it is possible that removal of SK2 channels by
TBS1 contributes, at least partly, to the reinstatement of LTP
by TBS2 delivered shortly after TBS1 in hippocampal slices
from AS mice. Our immunofluorescence results support the
notion that TBS1 induces SK2 internalization. Lin et al. also pro-
posed that LTP-induced SK2 internalization depended on PKA-
mediated phosphorylation and that direct SK2 phosphorylation
in the C-terminal domain may initiate its endocytosis (Lin et al.,
2008; Ren et al., 2006). Whether TBS1-induced SK2 removal in
AS mice also depends on PKA activation and whether this pro-
cess interacts with UBE3A-mediated SK2 ubiquitination are
currently under investigation.
LTD has been reported to be impaired in layer 2/3 synapses in
visual cortex in adult AS mice, although LTD is reliably induced
in these synapses in adult WT mice (Yashiro et al., 2009). In
contrast, it is difficult to reliably introduce LTD in the adult
hippocampus (Dudek and Bear, 1993), and our results showed
that this is the case in adult WT mice. However, stable LTD
was induced in hippocampal slices from AS mice, which was
blocked by apamin application. These results suggest that458 Cell Reports 12, 449–461, July 21, 2015 ª2015 The AuthorsSK2 upregulation in hippocampal CA1
synapses could be responsible for LTD
induction in adult AS mice. A recent study
reported that mGlu5-receptor-mediated
LTD was also enhanced in AS mice(Pignatelli et al., 2014). Of notice, mGlu5 receptors and SK2s
have been shown to form a reciprocally regulating complex
(Garcı´a-Negredo et al., 2014). Thus, it is possible that increased
synaptic SK2 levels contribute to mGlu5-receptor-mediated
LTD enhancement, and this question will be investigated in
future studies.
Role of UBE3A-Mediated Regulation of SK2s in Learning
and Memory
Previous studies, including our own, showed that, compared
with their WT littermates, AS mice exhibit a clear deficit in
context-dependent fear conditioning (Baudry et al., 2012; Jiang
et al., 1998; van Woerden et al., 2007). We previously showed
that a semi-chronic treatment with CX929 reversed the behav-
ioral deficit and re-established normal levels of freezing in
response to context and cue (Baudry et al., 2012). Manipulations
of SK2 activity have been shown to influence learning perfor-
mance in various paradigms (Deschaux et al., 1997; McKay
et al., 2012; Stackman et al., 2002). A recent study showed
that apamin enhanced contextual fear memory in WT mice
conditioned with one CS-US pairing protocol, but not with three
CS-US pairings (Vick et al., 2010). In the present study, we used
a three CS-US pairing protocol, and under this condition, apamin
had no effect on fear-conditioning learning inWTmice but signif-
icantly improved both context- and cue-dependent learning in
AS mice. These results support our hypothesis that in AS mice,
increased levels of synaptic SK2s are responsible for hippocam-
pal-dependent learning deficit. In summary, our results suggest
that synaptic SK2 endocytosis is directly regulated by UBE3A-
mediated ubiquitination and that this regulation is critically
involved in synaptic plasticity and learning performance, while
defects in this regulation could contribute to intellectual
disability, as seen in AS.
EXPERIMENTAL PROCEDURES
Mice
Animal experiments were conducted with protocols approved by the local
institutional animal care and use committee. Original UBE3A mutant (AS)
mice were obtained from The Jackson Laboratory (strain 129-Ube3atm1Alb/J),
and a breeding colony was established as previously described (Baudry
et al., 2012). In all experiments, male AS mice and WT littermates between 2
and 4 months of age were used.
Hippocampal Neuronal Cultures
Hippocampal neuronswere prepared from embryonic day 18 (E18) mouse em-
bryos, bred with UBE3Am/p+ female and male mice, as described previously
(Qin et al., 2009).
Cell Lines
COS-1 cells (ATCC) were grown in DMEM supplemented with 10% (v/v) fetal
bovine serum (FBS) (Invitrogen).
DNA Constructs, Transfection, Antibodies, and Peptides
For transient expression, cells were transfected with the respective constructs
and/or siRNA by lipofection (Lipofectamine 2000, Invitrogen).
Details regarding DNA constructs and antibodies can be found in the Sup-
plemental Experimental Procedures.
The following peptides were synthesized by ABI Scientific: PM101
(NYDKHV), PM102 (MENYDKHVSYN), TAT (YGRKKRRQRRR), and TAT-101
(YGRKKRRQRRRNYDKHV).
Subcellular Fractionation and Western Blot Analysis
Fractionation methods were modified from those of Smith et al. (2006) to yield
P2 and P3 fractions relatively enriched in postsynaptic density fractions
(PSDs). Western blots were performed according to published protocols
(Sun et al., 2015) with IRDye secondary antibodies and detected with the Od-
yssey imaging system.
Immunoprecipitation and Denaturing Immunoprecipitation
Immunoprecipitation was performed by incubating hippocampal P2 fractions
with appropriate antibodies and agarose beads following standard proce-
dures. For SK2 immunoprecipitation under denaturing conditions, P2 pellets
were heated in denaturing lysis buffer, diluted in ice-cold non-denaturing lysis
buffer, and then incubated with antibodies coupled to protein A/G agarose
beads.
In Vitro Ubiquitination Assay
GST-SK2 proteins containing the whole SK2 C terminus were expressed in
E. coli BL21 (DE3) and purified as previously described (Ren et al., 2006).
The E6AP (UBE3A) Ubiquitin Ligase Kit (Boston Biochem) containing E1 and
E2 enzyme (UBE2D3), His6-UBE3A, ubiquitin, Mg
2+-ATP, and reaction buffer
was used. For negative control reactions, ATP was omitted. Three indepen-
dent experiments were performed.
His-Ubiquitin Pull-Down Assay
COS-1 cells were transfected with His-ubiquitin plus Tac-SK2 or DK and HA-
UBE3A or HA-UBE3A C833A constructs, UBE3A, or control siRNA. Twenty-
four hours after transfection, cells were lysed, and His-ubiquitin-conjugated
proteins were purified as described previously (Xirodimas et al., 2001) with
minor modifications.
In Silico Molecular Docking
In silicomolecular dockingwas performed between the crystal structure of SK2
C-terminal helix (PDB: 2PNV, chain A 488–526) (Kim et al., 2008) and the crystal
structure of UBE3A (PDB: 1D5F) (Huang et al., 1999). Patchdock (Duhovny
et al., 2002; Schneidman-Duhovny et al., 2005) was used for docking.
Endocytosis Assay of Tac-SK2 in COS-1 Cells
Analysis of Tac-SK2 internalization was performed as previously reported
(Roche et al., 2001; Standley et al., 2000) and detailed in the SupplementalExperimental Procedures. In brief, cultured COS-1 cells were incubated with
Tac7G7 antibodies on ice, antibodies bound to Tac-SK2 were allowed to
be internalized, and internalized Tac-SK2 and surface-expressed Tac-SK2
were visualized by using two different fluorophore-conjugated secondary
antibodies.
Image Analysis and Quantification
Images were acquired using a Nikon C1 confocal laser-scanning microscope.
Acquisition parameters were kept identical among different experimental
groups. All immunostaining studies were performed in three to five indepen-
dent experiments. Tac-SK2 surface expression and internalization were
analyzed using ImageJ (NIH).
Neuronal Biotinylation Assay
Neuronal biotinylation assay was performed as previously reported (Roche
et al., 2001) and detailed in the Supplemental Experimental Procedures. In
brief, cultured hippocampal neuronswere incubated with sulfo-NHS-SS-biotin
(Pierce) on ice, and biotinylated proteins were either precipitated with
NeutrAvidin Agarose (Pierce) or allowed to be internalized and precipitated
after the remaining surface biotin was stripped.
Acute Hippocampal Slice Preparation, Electrophysiology, and
Phalloidin Staining
Acute slice preparation, recordings, and phalloidin staining of F-actin were
performed as previously described previously (Baudry et al., 2012; Wang
et al., 2014).
Immunofluorescence of Brain Tissue Sections
For immunofluorescence, brain sections (25 mm)were processed as previously
described (Sun et al., 2015; Wang et al., 2014).
Fear Conditioning
Male AS and WT mice were subjected to fear-conditioning testing as
described in the Supplemental Experimental Procedures. On training day,
mice were injected i.p. with apamin (0.4 mg/kg) 30min before training. Training
was conducted in a fear-conditioning chamber (H10-11M-TC, Coulbourn
Instruments) and behavior was recorded with the Freezeframe software and
analyzed with Freezeview software (Coulbourn Instruments).
Statistical Analysis
Error bars indicate SEM. To compute p values, an unpaired Student’s t test,
Kolmogorov-Smirnov test, and one- or two-way ANOVA with Newman-Keuls
or Bonferroni post test were used, as indicated in figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.06.023.
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